# FDA 483 - CSL Plasma Inc. - November 18, 2019

Source: https://www.keypedia.com/records/483/csl-plasma-inc/3eeaef2f-9699-45e3-bb58-67fc10c0b9ce

> FDA 483 for CSL Plasma Inc. on November 18, 2019. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: CSL Plasma Inc.
- Inspection Date: 2019-11-18
- Product Type: biologics
- Office Name: New Orleans District Office
- Summary: An FDA inspection of CSL Plasma, Inc. in Jackson, MS, a plasma center, revealed significant deficiencies in following written standard operating procedures. Observations included failures to properly handle damaged products and delays in reviewing critical error management issues. Additionally, the firm failed to adequately separate labeling operations, creating a risk of mix-ups.

## Related Officers

- [Juanelma H. Palmer](https://www.keypedia.com/people/juanelma-h-palmer/db3e79b5-d2d4-46d8-a075-4674dbc8c3d0)

Company: https://www.keypedia.com/companies/csl-plasma-inc/e12a9ae3-88a0-4915-b22b-f2ab3990d061

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea